Pediatric Glioblastoma: Clinico-radiological Profile and Factors Affecting the Outcome
Overview
Authors
Affiliations
Background And Purpose: Glioblastoma in the pediatric age group is relatively rare. As a result, it has been difficult to deduce any consistent clinico-radiological and pathological profiles on these patients. Also, the prognostic factors affecting the survival in pediatric glioblastoma are not as well defined as in adults.
Patients And Methods: In this retrospective series, 65 pediatric patients (age ≤ 18 years) from January 1995 to December 2011 with histopathologically proven diagnosis of intracranial glioblastoma were studied. Clinico-radiological, pathological, treatment, and follow-up data were collected. Progression-free and overall survivals were assessed using the Kaplan-Meier method.
Results: The male-to-female ratio was 2.6:1 with a mean age of 13.29 ± 4.53 years (range 2-18 years). Headache with or without vomiting (n = 51, 78 %), followed by seizures (n = 42, 65 %), and focal deficits (n = 31, 47 %) were the leading symptoms. Forty-nine (75 %) patients had tumors located superficially, whereas there were 16 patients with deeply located glioblastomas (25 %). Gross total tumor excision was achieved in 43 (66 %) patients, while the remaining patients had incomplete excision (n = 22, 34 %). Mean follow-up was 17.7 months (range 1.5-119 months). The median progression-free and overall survivals were 10 and 20 months, respectively. Extent of resection was found to be the independent predictor of survival (p value = 0.002).
Conclusion: Pediatric glioblastomas are associated with longer progression-free as well as overall survivals. Extent of tumor resection is the strongest predictor of survival in pediatric glioblastoma. Hence, an aggressive surgical resection may fetch a better outcome in children with glioblastoma.
Expression in Glioblastoma patients: Their Clinical and Prognostic Significance-A Prospective Study.
Meel M, Jindal A, Kumar M, Mathur K, Singh A Asian J Neurosurg. 2024; 19(1):14-20.
PMID: 38751398 PMC: 11093636. DOI: 10.1055/s-0042-1750783.
Glioblastoma stem cell metabolism and immunity.
Hawly J, Murcar M, Schcolnik-Cabrera A, Issa M Cancer Metastasis Rev. 2024; 43(3):1015-1035.
PMID: 38530545 DOI: 10.1007/s10555-024-10183-w.
Myeloid cells as potential targets for immunotherapy in pediatric gliomas.
Frederico S, Sharma N, Darling C, Taori S, Dubinsky A, Zhang X Front Pediatr. 2024; 12:1346493.
PMID: 38523840 PMC: 10960498. DOI: 10.3389/fped.2024.1346493.
Pediatric extra-axial glioblastoma with bone invasion leading to a subcutaneous mass: A case report.
Hammoud M, Hmamouche O, Lakhdar F, Benzagmout M, Chakour K, Chaoui M Surg Neurol Int. 2024; 15:25.
PMID: 38344102 PMC: 10858785. DOI: 10.25259/SNI_809_2023.
Almadhoun M, Hattab A Cureus. 2023; 15(10):e47697.
PMID: 38021881 PMC: 10674094. DOI: 10.7759/cureus.47697.